| Financial Year |
March 31 2023 |
| Monetary Funds |
376,066,059.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,626,824.44 |
| Accounts Receivable |
861,718,435.11 |
| Advances to Suppliers |
52,751,244.36 |
| Other Receivables |
25,926,989.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
677,869,365.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,096,991.00 |
| Other Current Assets |
57,008,819.41 |
| Total Current Assets |
2,130,104,006.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,723,916.54 |
| Investment Properties |
131,950,799.41 |
| Fixed Assetes |
261,398,754.24 |
| Under-construction Projects |
63,631,848.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,658,273.21 |
| R&D expenses |
-- |
| Goodwill |
31,953,343.41 |
| Long-Term Deferred and Prepaid Expenses |
21,013,095.28 |
| Deferred Income Tax Assets |
99,043,146.12 |
| Other Non-Current Assets |
76,743,833.05 |
| Sub-Total of Non-Current Assets |
1,029,873,260.06 |
| Total Assets |
3,159,977,266.12 |
| Short-Term Loans |
130,003,041.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
226,959,545.73 |
| Accounts Payable |
345,455,913.92 |
| Accounts Received In Advance |
1,874,961.11 |
| Employee Compensation Payable |
9,607,360.81 |
| Taxes Payable |
3,075,651.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
75,319,992.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,883,310.53 |
| Other Current Liabilities |
10,254,055.54 |
| Sub-Total of Current Liabilities |
887,763,010.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,370,544.84 |
| Other Non-Current Liabilities |
276,591.62 |
| Sub-Total of Non-Current Liabilities |
13,898,295.92 |
| Total Liabilities |
901,661,306.52 |
| Paid-In Capital(Or Share Stock) |
563,564,960.00 |
| Capital Surplus |
963,567,026.21 |
| Surplus Reserve |
93,180,473.10 |
| LESS:Treasury Stock |
60,311,060.00 |
| Undistributed Profits |
634,032,602.26 |
| Minority Stockholder's Interest |
20,577,259.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,237,738,700.60 |
| Owner's Equity（Stockholder's Equity） |
2,258,315,959.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,159,977,266.12 |
